Ontario Supporting Medical Research and Innovation in Sudbury
Province Investing $250,000 in Health Care Research
Ontario is investing in medical research being done in the Sudbury area that is working to develop a vaccine for a bacterium that can cause stomach cancer.
With an investment of $250,000 through the province's Northern Ontario Heritage Fund Corporation (NOHFC), Lilly Creek Vaccines Inc., a subsidiary of the Advanced Medical Research Institute of Canada, will continue its groundbreaking research in partnership with the National Research Council of Canada to develop and test a vaccine that will fight the bacterium, H.pylori. The bacteria live in the digestive tract and can lead to ulcers, gastritis and stomach cancer.
The H.pylori vaccine will be further developed and refined based on the results of the research, with the goal of using it for human clinical trials in Sudbury in the next two years.
Investing in medical research is part of the government's plan to build Ontario up. The four-part plan includes investing in people's talents and skills, making the largest investment in public infrastructure in Ontario's history, creating a dynamic, innovative environment where business thrives, and building a secure retirement savings plan.
- Since 2003, the NOHFC has invested more than $1 billion in 6,956 projects in Northern Ontario, creating or sustaining more than 26,000 jobs.
- The NOHFC’s investments in medical research are part of the Ontario government’s Growth Plan for Northern Ontario.
- Lilly Creek Vaccines Inc. was created by Advanced Medical Research Institute of Canada to bring to market potential new vaccines, drugs, and other treatments that have proven effective in laboratory studies.
- It is estimated that half of the world’s population carries H.pylori, especially in developing countries, due to less advanced sanitation and drinking water systems.
“By investing in this potentially life-saving project, our government is supporting cutting edge medical research and establishing the North as a centre for medical research.”
“Our investments in this health care project will help advance important research in the Sudbury area. I am very pleased with the province’s investment and support towards medical research in our community.”
“For more than 200 years, vaccines have been responsible for saving countless lives around the world. In fact, vaccines are often the most effective way to prevent serious illness. Finding a vaccine for H.pylori will have major positive health impacts, globally, and help maintain Canada's place as a world leader in health research and innovation.”
“We are delighted with this investment that will assist us with building a Sudbury-based, globally recognized biotechnology company. NOHFC participation is a critical first step in capital formation and the advancement of this unique approach to solving a public health problem.”
“H.pylori has some very serious health consequences and like many other bacteria, it has become more resistant to the antibiotics and other medicines we are using to treat it. If we can discover and develop an effective vaccine for H.pylori, it could have a huge impact on public health and infectious disease around the world.”
Dr. Francisco Diaz-Mitoma
“Advanced Medical Research Institute of Canada’s efforts to find a vaccine for H.pylori again demonstrate how research is inseparable from the best patient care. It is research that drives innovations and breakthroughs in health care, and this project is another example of the world-class work being done in Sudbury.”
Dr. Denis Roy